Teladoc (NYSE: TDOC) saw its stock lose about half its value after announcing a $6.6 billion impairment charge amid a challenging integration of Livongo and its health management app. TDOC shares today are trading around $30 apiece, down 50% from where they were before yesterday’s Q1 earnings announcement. Teladoc closed its $18.5 billion purchase of […]
Livongo
MedTech 100 roundup: Stocks show no signs of slowing down
The medtech industry hit further highs in the market last week and the stocks show no sign of stopping their ascent now. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week at 97.62 (Nov. 6), marking a 7.3% leap from the 91.01 points registered at the […]
Teladoc closes $18.5B Livongo buy
Teladoc (NYSE:TDOC) has closed its $18.5 billion purchase of Livongo Health (NSDQ:LVGO) ahead of schedule. The companies entered into a definitive merger agreement in August and closed the deal Oct. 30. Under the terms of the merger, Livongo shareholders will receive 0.5920 shares of Teladoc Health plus cash of $11.33 for each Livongo share, including a special […]
Livongo slides on Street-beating Q3 results
Livongo Health (NSDQ:LVGO) reported third-quarter results today that beat the consensus on Wall Street. The Mountain View, Calif.-based company reported losses of -$25.5 million, or -26¢ per share, on sales of $106.1 million for the three months ended Sept. 30, for a sales growth of 126.4% compared with Q3 2019. Adjusted to exclude one-time items, earnings […]
Livongo, Teladoc divulge more details of proposed $18.5M merger
Teladoc (NYSE:TDOC) and Livongo Health (NSDQ:LVGO) today filed a joint proxy statement in connection with a proposed merger. Last month, the companies entered into a definitive merger agreement worth approximately $18.5 million. At the time, each share of Livongo was set to be exchanged for 0.5920 shares of Teladoc, plus cash consideration of $11.33 per Livongo share, […]
MedTech 100 roundup: Up-and-down week for industry
Medtech stocks highlighted the topsy-turvy nature of the market last week, but ultimately finished the seven days nearly unchanged. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 89.77 points at the end of last week (Aug. 14). Overall, medtech stocks saw a 0.13% increase from the […]
Livongo slides despite Street-beating Q2
Livongo Health (NSDQ:LVGO) shares took a hit today on second-quarter results that came in ahead of the consensus forecast. The Mountain View, Calif.-based company posted losses of -$1.6 million, or -2¢ per share, on sales of $91.9 million for the three months ended June 30, 2020, for an 88% bottom-line gain while more than doubling its […]
MedTech 100 roundup: Another high as stocks tick up
For the third consecutive week, stocks in the medtech industry reached heights not yet seen since the COVID-19 pandemic began. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 89.65 points at the end of last week (Aug. 7). Overall, medtech stocks saw a 0.72% increase from […]
Teladoc to acquire Livongo for $18.5B
Teladoc (NYSE:TDOC) announced today that it entered into a definitive merger agreement with Livongo Health (NSDQ:LVGO) worth $18.5 billion. Purchase, N.Y.-based Teladoc and Mountain View, Calif.-based Livongo are setting out to improve the delivery, access and experience of healthcare around the world by offering high-quality, technology-enabled longitudinal care, according to a news release. Under the agreement, […]
Livongo announces $400m offering
Livongo Health (NSDQ:LVGO) announced that it intends to offer $400 million in a private offering of convertible senior notes. Mountain View, Calif.-based Livongo also plans to grant the initial purchasers of the notes, due in 2025, a 13-day option to purchase up to an additional $60 million, according to a news release. The notes will be […]
COVID-19 upends medtech’s financial outlook
The uncertain times brought on by the COVID-19 pandemic have affected businesses worldwide, and several sectors of medtech industry are projecting hits to their bottom lines. A number of companies have announced decisions to withdraw financial guidance, cut hours and/or staff, among other major business decisions. Initial impacts of the global pandemic on Wall Street […]
